Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: Results of the first year

International Journal of Cancer

Volumn 103, Issue 3, 2003, Pages 422-426

  Nieminen, Pekka ^a   Hakama, Matti ^b,c   Viiki, Merja ^c   Tarkkanen, Jussi ^a   Antilla, Ahti ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c FINNISH CANCER REGISTRY   (Finland)

Author keywords

Automation assisted; Cervical cancer; Papnet; Primary screening; Public health trial

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL NEURAL NETWORK; AUTOMATION; CANCER DIAGNOSIS; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FINLAND; HEALTH CARE POLICY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASS SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA;

ADULT; CARCINOMA IN SITU; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; FINLAND; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEURAL NETWORKS (COMPUTER); PROSPECTIVE STUDIES; PUBLIC HEALTH; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0037454764     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10839     Document Type: Article

References (16)

1. Hakama M. Trends in the incidence of cervical cancer in the Nordic Countries. In: Magnus K, ed. Trends in Cancer Incidence. Causes and Practical Implications. New York: Hemisphere, 1982;279-292.
2. Läärä E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries; Association with organized screening programmes. Lancet 1987;1:1247-9.
3. Nieminen P, Kallio M, Anttila A, Hakama M. Organized vs. spontaneous Pap-smear screening for cervical cancer: A case control study. Int J Cancer 1999;83:55-8.
4. Hristova L, Hakama M. Effect of screening for cancer in the Nordic countries on deaths, costs and quality of life up to the year 2017. Acta Oncol 1997;36(Suppl):1-60.
5. Anttila A, Pukkala E, Soderman B, Kallio M, Nieminen P, Hakama M. Effect of organized screening on cervical cancer incidence and mortality in Finland, 1963-1995: A recent increase in the incidence. Int J Cancer 1999;83:59-63.
6. Kok MR, Boon ME. Consequences of neural network technology for cervical screening: Increase in diagnostic consistency and positive scores. Cancer 1996;78:112-7.
7. Kok MR, Boon ME, Schreiner-Kok PG, Koss LG. Cytological recognition of invasive squamous cancer of the uterine cervix: Comparison of conventional light-microscopical screening and neural-network-based screening. Hum Pathol 2000;31:23-8.
8. PRISMATIC Project Management Team. Assessment of automated primary screening on PAPNET of cervical smears in the PRISMATIC trial. Lancet 1999;353:1381-5.
9. Doornewaard H, van der Schouw YT, van der Graaf Y, Bos AB, Habbema JD, van den Tweel JG. The diagnostic value of computerassisted primary cervical smear screening: A longitudinal cohort study. Mod Pathol 1999;12:995-1000.
10. Koss LG, Sherman ME, Cohen MB, Anes AR, Darragh TM, Lemos LB, McClellan BJ, Rosenthal DL, Keyhani-Rofagha S, Schreiber K, Valente PT. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET testing system). Hum Pathol 1997;28:1196-203.
11. Halford JA, Wright RG, Ditchmen EJ. Prospective study of PAPNET: Review of 25,656 Pap smears negative on manual screening and rapid rescreening. Cytopathology 1999;10:317-23.
12. Bergeron C, Masseroli M, Ghezi A, Lemarie A, Mango L, Koss LG. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening. Acta Cytol 2000;44:151-7.
13. Duggan MA. Papnet-assisted, primary screening of cervico-vaginal smears. Eur J Gynaecol Oncol 2000;21:35-42.
14. Agresti A, Min Y. On small-sample confidence intervals for parameters in discrete distributions. Biometrics 2001;57:963-71.
15. Michelow PM, Hlongwane NF, Leiman G. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community. Acta Cytol 1997;41:88-92.
16. Fahey M, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.